Skip to main content
Equibles

Erik Lundgren

CEO

Immunic, Inc. (IMUX)

Board Member

Immunic, Inc. (IMUX)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Erik Lundgren

Erik Lundgren is recorded as CEO and Board Member at Immunic, Inc. (IMUX). Immunic, Inc. reported in an 8-K filed August 11, 2026 that Erik Lundgren was appointed Director of the Board, effective July 5, 2026. Immunic, Inc. reported in an 8-K filed August 11, 2026 that Erik Lundgren was appointed Chief Executive Officer, effective May 22, 2026. Immunic, Inc. reported in an 8-K filed July 6, 2026 that Erik Lundgren was appointed Class II director, effective July 5, 2026. Equibles holds 5 filed executive changes naming Erik Lundgren; each is listed under recent activity with its source filing.

“On July 5, 2026, Mr. Lundgren was also appointed to serve as a Director of the Board.”
Immunic, Inc. Form 8-K, filed August 11, 2026 · Read the filing
“Appointment of Erik Lundgren as Chief Executive Officer, effective May 22, 2026, with employment having begun on June 1, 2026.”
Immunic, Inc. Form 8-K, filed August 11, 2026 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Immunic, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.